#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	17030	16S	1529	1529	99.93	16S.l15.c17.ctg.1	1937	858.9	0	.	n	.	0	C1450T	SNP	1450	1450	C	1649	1649	T	958	T	907	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	17030	16S	1529	1529	99.93	16S.l15.c17.ctg.1	1937	858.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1383	1383	C	952	C	918	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	17030	16S	1529	1529	99.93	16S.l15.c17.ctg.1	1937	858.9	0	HET	.	.	.	C469T,G	.	469	469	C	668	668	C	957	C,T,G	686,226,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	32412	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3572	895.5	0	.	n	.	0	T695C	SNP	695	695	T	1051	1051	C	955	C,T	912,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	32412	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3572	895.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2327	2327	C	982	C	950	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	32412	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3572	895.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2401	2401	A	1000	A	970	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	32412	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3572	895.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2953	2953	C	1025	C	988	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	32412	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3572	895.5	0	HET	.	.	.	A2189G	.	2189	2189	A	2545	2545	A	970	A,G	695,235	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	32412	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3572	895.5	0	HET	.	.	.	C1179T,A	.	1179	1179	C	1535	1535	C	1135	C,T,A	847,223,1	.	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	1892	folP	852	852	99.88	folP.l6.c4.ctg.1	1529	122.2	0	.	p	.	0	A204V	NONSYN	610	612	GCA	951	953	GTA	151;153;153	G;T,C;A,G	151;149,1;148,1	.	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	1892	folP	852	852	99.88	folP.l6.c4.ctg.1	1529	122.2	1	SNP	p	R228S	0	.	.	682	684	CGC	1023	1025	CGC	176;176;176	C,A;G,A;C	171,1;168,1;168	folP.WHO_F_01537c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5412	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3377	158.2	1	SNP	p	S91F	0	.	.	271	273	TCC	569	571	TCC	193;193;196	T;C,T;C	180;184,1;190	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5412	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3377	158.2	1	SNP	p	D95N	0	.	.	283	285	GAC	581	583	GAC	201;201;199	G,A;A;C	194,1;190;192	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5412	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3377	158.2	1	SNP	p	D95G	0	.	.	283	285	GAC	581	583	GAC	201;201;199	G,A;A;C	194,1;190;192	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	27	1792	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1372	128.9	1	SNP	p	G45D	1	.	.	133	135	GAC	530	532	GAC	212;212;212	G;A,G;C	202;201,1;204	mtrR.WHO_M_01390:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1040	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	995	103.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5782	parC	2304	2304	99.74	parC.l6.c30.ctg.1	3073	186.1	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1637	1639	GCA	212;213;210	G;C,A,G;A	207;195,1,1;198	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5782	parC	2304	2304	99.74	parC.l6.c30.ctg.1	3073	186.1	0	.	p	.	0	V596I	NONSYN	1786	1788	GTT	2120	2122	ATT	239;243;241	A;T;T,C	222;227;225,1	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5782	parC	2304	2304	99.74	parC.l6.c30.ctg.1	3073	186.1	0	.	p	.	0	V646A	NONSYN	1936	1938	GTG	2270	2272	GCG	207;208;206	G;C,T;G,C	196;196,1;200,1	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5782	parC	2304	2304	99.74	parC.l6.c30.ctg.1	3073	186.1	1	SNP	p	D86N	0	.	.	256	258	GAC	590	592	GAC	221;221;225	G,A;A;C	213,1;213;218	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5782	parC	2304	2304	99.74	parC.l6.c30.ctg.1	3073	186.1	1	SNP	p	S87W	0	.	.	259	261	AGT	593	595	AGT	227;230;233	A,C;G;T	218,1;224;223	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5782	parC	2304	2304	99.74	parC.l6.c30.ctg.1	3073	186.1	1	SNP	p	S87I	0	.	.	259	261	AGT	593	595	AGT	227;230;233	A,C;G;T	218,1;224;223	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5782	parC	2304	2304	99.74	parC.l6.c30.ctg.1	3073	186.1	1	SNP	p	S87R	0	.	.	259	261	AGT	593	595	AGT	227;230;233	A,C;G;T	218,1;224;223	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5782	parC	2304	2304	99.74	parC.l6.c30.ctg.1	3073	186.1	1	SNP	p	S88P	0	.	.	262	264	TCC	596	598	TCC	230;228;226	T;C;C	222;219;220	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4176	parE	1986	1986	99.85	parE.l15.c4.ctg.1	2677	154.1	0	.	p	.	0	V89A	NONSYN	265	267	GTC	661	663	GCC	211;211;209	G;C,T;C	193;201,1;189	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4176	parE	1986	1986	99.85	parE.l15.c4.ctg.1	2677	154.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1624	1626	GGC	183;182;181	G;G;C	180;179;176	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	4098	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2378	169.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1212	1214	GCA	206;208;208	G;C;A	197;198;203	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4098	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2378	169.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1215	1217	ATC	212;211;213	A;T;C	206;204;209	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4098	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2378	169.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1227	1229	GTG	208;206;206	G;T;G	204;201;202	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4098	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2378	169.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1227	1229	GTG	208;206;206	G;T;G	204;201;202	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4098	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2378	169.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1731	1733	ACC	212;212;207	A;C;C	200;205;201	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4098	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2378	169.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1785	1787	GCG	180;178;182	G;C,G;G,T	169;157,1;168,2	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4098	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2378	169.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1785	1787	GCG	180;178;182	G;C,G;G,T	169;157,1;168,2	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4098	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2378	169.8	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1908	1910	GGT	155;156;160	G;G;T	148;148;150	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4098	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2378	169.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1917	1919	GGC	157;154;153	G;G;C	146;143;141	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4098	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2378	169.8	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1935	1937	CCG	145;146;146	C,G;C;G	118,1;132;130	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6744	ponA	2397	2397	100.0	ponA.l6.c30.ctg.1	3095	214.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1658	1660	CCG	233;229;231	C,G;C;G,C	217,1;221;215,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2394	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1996	118.3	0	.	p	.	0	S22G	NONSYN	64	66	AGC	575	577	GGC	145;142;145	G,A;G;C	138,1;135;139	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2394	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1996	118.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	757	757	C	181	C	170	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3296	porB1b	1035	1035	98.66	porB1b.l15.c30.ctg.1	1522	213.5	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	964	964	T	253	T,C	237,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3296	porB1b	1035	1035	98.66	porB1b.l15.c30.ctg.1	1522	213.5	1	SNP	p	G120K	0	.	.	358	360	GGT	691	693	GGT	263;260;258	G,A;G,A;T,G	247,1;248,1;234,3	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3296	porB1b	1035	1035	98.66	porB1b.l15.c30.ctg.1	1522	213.5	1	SNP	p	A121N	0	.	.	361	363	GCC	694	696	GCC	251;249;249	G,A;C,A;C	239,1;238,1;235	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3296	porB1b	1035	1035	98.66	porB1b.l15.c30.ctg.1	1522	213.5	1	SNP	p	A121D	0	.	.	361	363	GCC	694	696	GCC	251;249;249	G,A;C,A;C	239,1;238,1;235	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	12042	rpoB	4179	4179	100.0	rpoB.l15.c17.ctg.1	4912	242.1	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2105	2107	CAT	244;246;250	C;A;T	237;236;241	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	1404	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1013	136.8	1	SNP	p	V57M	0	.	.	169	171	GTG	515	517	GTG	278;276;276	G;T;G	271;264;268	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
